In a new job - September 17, 2019
She is the new Head of the FIMM Technology Centre
Dr Katja Kivinen has been appointed new Head of the FIMM Technology Centre and she started her new position on September 16, 2019. Katja Kivinen has expertise in both genetics and bioinformatics, and recently, she has contributed significantly to the development of cardiovascular research at the University of Cambridge. Her interests include the development and […]
In a new job - February 27, 2018
New Director at FIMM
The University of Helsinki has recruited Professor Mark Daly of the Broad Institute of MIT and Harvard and Massachusetts General Hospital to lead the Institute for Molecular Medicine Finland (FIMM). Daly succeeds Academy Professor Jaakko Kaprio, and has been appointed with effect from February 1, 2018. While spending most of his time in Finland, Daly will continue […]
Collaboration - January 2, 2017
Global partnership for multiple sclerosis launched
A global partnership called ‘MultipleMS’, coordinated by Karolinska Institute, has been awarded 15 million euro from the European Commission in the Horizon2020 program to find novel and better treatments for Multiple Sclerosis (MS). In this project, universities and companies across 12 European countries and the US will unite efforts to tailor the development and application […]
Uncategorized - November 21, 2016
Improved prediction of prostate cancer survival
Results of the Prostate Cancer DREAM Challenge published in the clinical oncology journal Lancet Oncology demonstrate the benefits of sharing clinical trial data. The winning prediction model was developed by a team headed by FIMM Group Leader Tero Aittokallio. Overall, this collaborative scientific effort led to novel insights and improvements in cancer treatment and management. In 2015, professor Aittokallio’s team excelled in Sage […]
Pharma Award - November 8, 2016
Revolutionizing drug discovery
Jing Tang from the Institite of Molecular Medicine Finland (FIMM) has been awarded one of the prestigious ERC Starting Grants by the European Research Council. The 5-year grant totals 1.5 million euros. Tang’s project utilises computational systems medicine approaches, and aims to develop new ways to identify personalised drug combinations that are more effective against […]
Uncategorized - August 12, 2016
New treatment for acute leukemia
FIMM researchers have demonstrated that a previously approved drug called idelalisib is a promising treatment option for leukemia patients with the t(1;19) translocation. Fusion genes are hybrids formed from two separate genes by structural genomic rearrangements. They play an important role in tumorigenesis, and they are often found in leukemias and other types of cancer. […]
